These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38463028)

  • 21. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway.
    Yan Z; Xu T; Lu J; Wu Z; Li X; Xu J; Guo W; Dong Z
    Pathol Res Pract; 2022 Aug; 236():153963. PubMed ID: 35662041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FBXW7 loss of function promotes esophageal squamous cell carcinoma progression via elevating MAP4 and ERK phosphorylation.
    Pan Y; Liu J; Gao Y; Guo Y; Wang C; Liang Z; Wu M; Qian Y; Li Y; Shen J; Lu C; Ma S
    J Exp Clin Cancer Res; 2023 Mar; 42(1):75. PubMed ID: 36991467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma.
    Chen Q; Zhang L; Wan C; Yang B; Kong X; Xu X; Gu Y; Wang C; Liu X; Ding Q; Zhu L; Li Y; Wang B; Zhong W
    Int J Oncol; 2023 Jul; 63(1):. PubMed ID: 37203411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing of UAP1L1 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma.
    Xiao X; Jiang L; Hu H; Huang Y; Yang L; Jiao Y; Wei G
    Mol Carcinog; 2021 Mar; 60(3):179-187. PubMed ID: 33434300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis.
    Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F
    Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
    Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
    Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SH2D4A inhibits esophageal squamous cell carcinoma progression through FAK/PI3K/AKT signaling pathway.
    Shi H; Luo J; Ye L; Duan C; Zhang M; Ran H; Li C; Wu Q; Shao Y
    Cell Signal; 2024 Feb; 114():110997. PubMed ID: 38043670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR.
    Zeng W; Zhu JF; Liu JY; Li YL; Dong X; Huang H; Shan L
    Biomed Pharmacother; 2019 Mar; 111():476-484. PubMed ID: 30594787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAI-1 overexpression promotes invasion and migration of esophageal squamous carcinoma cells.
    Wang D; Yang LY; Liu Z; Yu J; Zhang MJ; Zhang Y; Cai Y; Xu X; Hao JJ; Wang MR
    Yi Chuan; 2020 Mar; 42(3):287-295. PubMed ID: 32217514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing of Rab3D suppresses the proliferation and invasion of esophageal squamous cell carcinoma cells.
    Zhang J; Kong R; Sun L
    Biomed Pharmacother; 2017 Jul; 91():402-407. PubMed ID: 28472755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA RPL34-AS1 suppresses the proliferation, migration and invasion of esophageal squamous cell carcinoma via targeting miR-575/ACAA2 axis.
    Zhang H; Pan E; Zhang Y; Zhao C; Liu Q; Pu Y; Yin L
    BMC Cancer; 2022 Sep; 22(1):1017. PubMed ID: 36162992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. USP4 promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting TAK1.
    Zhang H; Han Y; Xiao W; Gao Y; Sui Z; Ren P; Meng F; Tang P; Yu Z
    Cell Death Dis; 2023 Nov; 14(11):730. PubMed ID: 37949874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [SERPINE2 promotes cellular migration and invasion in esophageal squamous cell carcinoma by activating β-catenin].
    Zhang JL; Luo AP; Huang FR; Gong TY; Liu ZH
    Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):638-645. PubMed ID: 34289555
    [No Abstract]   [Full Text] [Related]  

  • 34. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
    Zhang J; Liu S; Zhang D; Ma Z; Sun L
    J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
    Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
    J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [En1 promotes cell proliferation and migration via Hedgehog signaling pathway in esophageal squamous cell carcinoma].
    Zhao N; Gong TY; Wei ZC; Cong J; Liu ZH; Chen HY
    Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):99-107. PubMed ID: 38418183
    [No Abstract]   [Full Text] [Related]  

  • 37. A novel protein encoded by circUBE4B promotes progression of esophageal squamous cell carcinoma by augmenting MAPK/ERK signaling.
    Lyu Y; Tan B; Li L; Liang R; Lei K; Wang K; Wu D; Lin H; Wang M
    Cell Death Dis; 2023 Jun; 14(6):346. PubMed ID: 37264022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. USP18 promotes tumor metastasis in esophageal squamous cell carcinomas via deubiquitinating ZEB1.
    Song C; Peng J; Wei Y; Shao J; Chen X; Zhang X; Xu J
    Exp Cell Res; 2021 Dec; 409(1):112884. PubMed ID: 34743935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TESC acts as a prognostic factor and promotes epithelial-mesenchymal transition progression in esophageal squamous carcinoma.
    Dong Y; Fan B; Li M; Zhang J; Xie S; Di S; Jia Q; Gong T
    Pathol Res Pract; 2024 Jan; 253():154964. PubMed ID: 38000203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.